FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
As Fewer MDs Practice Rural Primary Care, a Different Type of Doctor Helps Take Up the Slack
Tony Leys WINTERSET, Iowa — For 35 years, this town’s residents have brought all manner of illnesses, aches, and worries
Read More